134 related articles for article (PubMed ID: 15832372)
1. Biological evaluation of penetration domain and killing domain peptides.
Jarajapu YP; Baltunis J; Knot HJ; Sullivan SM
J Gene Med; 2005 Jul; 7(7):908-17. PubMed ID: 15832372
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition of glioblastoma cells by human Pur(alpha).
Darbinian N; Gallia GL; King J; Del Valle L; Johnson EM; Khalili K
J Cell Physiol; 2001 Dec; 189(3):334-40. PubMed ID: 11748591
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 TAT protein transduction domain mediates enhancement of enzyme prodrug cancer gene therapy in vitro: a study with TAT-TK-GFP triple fusion construct.
Meriläinen O; Hakkarainen T; Wahlfors T; Pellinen R; Wahlfors J
Int J Oncol; 2005 Jul; 27(1):203-8. PubMed ID: 15942661
[TBL] [Abstract][Full Text] [Related]
4. The metal-binding domain of IGFBP-3 selectively delivers therapeutic molecules into cancer cells.
Huq A; Singh B; Meeker T; Mascarenhas D
Anticancer Drugs; 2009 Jan; 20(1):21-31. PubMed ID: 19342998
[TBL] [Abstract][Full Text] [Related]
5. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
Ziegler A; Nervi P; Dürrenberger M; Seelig J
Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
[TBL] [Abstract][Full Text] [Related]
6. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.
Gupta B; Levchenko TS; Torchilin VP
Adv Drug Deliv Rev; 2005 Feb; 57(4):637-51. PubMed ID: 15722168
[TBL] [Abstract][Full Text] [Related]
7. Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy.
Rautsi O; Lehmusvaara S; Ketola A; Määttä AM; Wahlfors J; Pellinen R
Cancer Gene Ther; 2008 May; 15(5):303-14. PubMed ID: 18309353
[TBL] [Abstract][Full Text] [Related]
8. An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells.
Sauer I; Dunay IR; Weisgraber K; Bienert M; Dathe M
Biochemistry; 2005 Feb; 44(6):2021-9. PubMed ID: 15697227
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
10. A peptide carrier for the delivery of biologically active proteins into mammalian cells.
Morris MC; Depollier J; Mery J; Heitz F; Divita G
Nat Biotechnol; 2001 Dec; 19(12):1173-6. PubMed ID: 11731788
[TBL] [Abstract][Full Text] [Related]
11. Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo.
Gratton JP; Yu J; Griffith JW; Babbitt RW; Scotland RS; Hickey R; Giordano FJ; Sessa WC
Nat Med; 2003 Mar; 9(3):357-62. PubMed ID: 12598894
[TBL] [Abstract][Full Text] [Related]
12. Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides.
Snyder EL; Saenz CC; Denicourt C; Meade BR; Cui XS; Kaplan IM; Dowdy SF
Cancer Res; 2005 Dec; 65(23):10646-50. PubMed ID: 16322205
[TBL] [Abstract][Full Text] [Related]
13. Protein transduction: an alternative to genetic intervention?
Ford KG; Souberbielle BE; Darling D; Farzaneh F
Gene Ther; 2001 Jan; 8(1):1-4. PubMed ID: 11402295
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide.
Anderson DC; Nichols E; Manger R; Woodle D; Barry M; Fritzberg AR
Biochem Biophys Res Commun; 1993 Jul; 194(2):876-84. PubMed ID: 8343170
[TBL] [Abstract][Full Text] [Related]
15. Organelle-targeted delivery of biological macromolecules using the protein transduction domain: potential applications for Peptide aptamer delivery into the nucleus.
Yoshikawa T; Sugita T; Mukai Y; Yamanada N; Nagano K; Nabeshi H; Yoshioka Y; Nakagawa S; Abe Y; Kamada H; Tsunoda S; Tsutsumi Y
J Mol Biol; 2008 Jul; 380(5):777-82. PubMed ID: 18571668
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient, nonpeptidic oligoguanidinium vectors that selectively internalize into mitochondria.
Fernández-Carneado J; Van Gool M; Martos V; Castel S; Prados P; de Mendoza J; Giralt E
J Am Chem Soc; 2005 Jan; 127(3):869-74. PubMed ID: 15656624
[TBL] [Abstract][Full Text] [Related]
17. Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells.
Tünnemann G; Martin RM; Haupt S; Patsch C; Edenhofer F; Cardoso MC
FASEB J; 2006 Sep; 20(11):1775-84. PubMed ID: 16940149
[TBL] [Abstract][Full Text] [Related]
18. Rational design of shepherdin, a novel anticancer agent.
Plescia J; Salz W; Xia F; Pennati M; Zaffaroni N; Daidone MG; Meli M; Dohi T; Fortugno P; Nefedova Y; Gabrilovich DI; Colombo G; Altieri DC
Cancer Cell; 2005 May; 7(5):457-68. PubMed ID: 15894266
[TBL] [Abstract][Full Text] [Related]
19. Lmo7 is an emerin-binding protein that regulates the transcription of emerin and many other muscle-relevant genes.
Holaska JM; Rais-Bahrami S; Wilson KL
Hum Mol Genet; 2006 Dec; 15(23):3459-72. PubMed ID: 17067998
[TBL] [Abstract][Full Text] [Related]
20. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5.
Goda N; Tenno T; Inomata K; Shirakawa M; Tanaka T; Hiroaki H
Exp Cell Res; 2008 Aug; 314(13):2352-61. PubMed ID: 18602100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
